Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?

• click to rate

  Posted by Two Blokes Jun 19 - Filed in Stock - 1 view
  
  PFE's oncology portfolio, boosted by Seagen and late-stage pipeline assets, may fuel growth amid lackluster stock performance.